Selank is currently one of the most researched peptides specifically for anxiety-related applications and emotional regulation
However, we recognize that every patient is unique
Further research by University Hospitals in Cleveland, examining over 336,000 individuals, discovered that the likelihood of developing gastroparesis increases after six months of GLP-1 therapy
Microglia, the resident immune cells in the CNS, function as brain macrophages and are essential in modulating neuroinflammation when activated under inflammatory conditions [100, 101]
A few early studies suggest that GLP-1 drugs may also help protect against cancer
Evidence against a universal class effect However, one case provides a compelling counterexample